1-(2-METHOXYETHYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID, 95.0%, 1g

2-(3-(ETHOXYCARBONYL)-4-METHYL-1H-PYRAZOL-1-YL)BENZOIC ACID, 90.0%, 500mg

3,3-dichloro-1-(3-nitrophenyl)piperidin-2-one, 97%, 250mg

Bromoethane, min 99.5%, for synthesis, 1L, glass packaging

N-ethyl-2-(3-ethylphenoxy)ethanamine hydrochloride, 95.0%, 1g

tert-Butyl (1,3-dihydroxypropan-2-yl)carbamate, 95.0%, 10g

3-BROMO-2-CHLORO-6-FLUOROPYRIDINE, 95.0%, 5g

ethyl 2-(2-chlorophenyl)ethanecarboximidate hydrochloride, 95.0%, 10g

(S)-1-(tert-Butoxycarbonyl)-2-methylpiperazine>98.0%(GC)(T)1g

2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 10g

Methyl 2-fluoro-6-methoxybenzoate, 98.0%, 25g

Ethyl 2-amino-3,4-difluorobenzoate, 98%, 250mg

3-Bromo-5-(pentafluorosulfur)benzaldehyde, 5g